麻酔薬市場：薬剤タイプ、投与経路、用途、投与形態、エンドユーザー別-2025-2030年の世界予測

麻酔薬市場は、2023年に50億3,000万米ドルと評価され、2024年には53億5,000万米ドルに達すると予測され、CAGR 6.54％で成長し、2030年には78億3,000万米ドルに達すると予測されています。

麻酔薬市場には、外科手術や疼痛管理に使用されるさまざまな医薬品が含まれます。これらの医薬品には、全身麻酔薬、局所麻酔薬、局所麻酔薬などが含まれ、患者の感覚喪失を誘発するために重要であるため、医療専門家は複雑な手術を安全かつ苦痛を最小限に抑えて行うことができます。麻酔薬の必要性は、軽微な外来処置から複雑で侵襲的な手術まで、さまざまな手術に応用されていることからも明らかです。さらに、世界人口の高齢化と外科手術の増加に伴い、効果的な麻酔薬に対する需要は増加する傾向にあります。この市場では、病院、外来手術センター、診療所が主要な最終用途分野となっています。薬剤製剤の進歩は回復時間の短縮と副作用の軽減を約束し、世界の医療費の増加は市場の拡大を促進します。さらに、低侵襲手術の出現や外来手術の動向の高まりは、麻酔薬の応用を拡大しています。しかし、市場は厳しい規制要件や麻酔薬使用に伴う潜在的な副作用などの制限に直面しており、これが市場開拓を抑制する可能性があります。さらに、ヘルスケアインフラが限られている地域では、これらの薬剤へのアクセスが依然として課題となっています。強い可能性を秘めた技術革新と研究分野には、遺伝子プロファイリングに基づくより個別化された麻酔ソリューションの開発や、薬効と安全性を向上させるナノテクノロジーなどのドラッグデリバリーシステムの強化などがあります。製薬会社と研究機関の新たな提携や協力関係はイノベーションを加速させる可能性があり、企業は技術の進歩や規制の変化に遅れを取らないことが重要です。市場情勢は大きな成長を遂げようとしているが、その可能性を最大限に活用するためには、複雑な状況を戦略的にナビゲートする必要があります。

市場力学：急速に進化する麻酔薬市場の主要市場インサイトを公開

麻酔薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界中で実施される手術件数の増加
  • 術後疼痛緩和オプションに対する需要の大幅な伸び
  • 高齢化人口の増加と心臓血管系および呼吸器系関連疾患の流行
• 市場抑制要因
  • ケタミンなどの薬剤に伴う副作用
• 市場機会
  • ドラッグデリバリー技術の進歩
  • 医療費の増加と新薬の開発
• 市場の課題
  • 熟練麻酔医の不足

ポーターのファイブフォース麻酔薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：麻酔薬市場における外部からの影響の把握

外部マクロ環境要因は、麻酔薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析麻酔薬市場における競合情勢の把握

麻酔薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス麻酔薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、麻酔薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨麻酔薬市場における成功への道筋を描く

麻酔薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で実施される手術件数の増加
    • 術後疼痛緩和オプションの需要が大幅に増加
    • 高齢化人口の増加と心血管系および呼吸器系関連疾患の罹患率
  • 抑制要因
    • ケタミンなどの薬物に伴う副作用
  • 機会
    • ドラッグデリバリー技術の進歩
    • ヘルスケア費の増加と新薬の開発
  • 課題
    • 熟練した麻酔科医の不足
• 市場セグメンテーション分析
  • 薬剤の種類：広範囲かつ侵襲的な手術のための全身麻酔薬の重要な必要性
  • 応用：効果的な疼痛管理を促進するための一般外科手術における麻酔薬の活用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 麻酔薬市場薬の種類別

• 全身麻酔薬
• 局所麻酔薬
• 局所麻酔

第7章 麻酔薬市場：投与経路別

• 吸入
• 注射

第8章 麻酔薬市場：用途別

• 美容整形
• 歯科手術
• 一般外科
• 形成外科

第9章 麻酔薬市場投与方法別

• 吸入
• 静脈内

第9章 4.話題性：

第10章 麻酔薬市場：エンドユーザー別

• 外来手術センター
• クリニック
• 病院

第11章 南北アメリカの麻酔薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の麻酔薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの麻酔薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • バクスターインターナショナル社、革新的な注射剤で米国ポートフォリオを拡大
  • ヒクマ・ファーマシューティカルズ、フェンタニルクエン酸塩注射剤の発売により米国市場での提供を拡大
  • 術後疼痛管理の進歩：FDAによる長期持続性局所麻酔薬の開発に関する新しいガイドライン
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Apotex Inc.
• Aspen Pharmacare Holdings Limited
• AstraZeneca PLC
• B. Braun Melsungen AG by B. Braun SE
• Baxter International Inc.
• Boehringer Ingelheim International GmbH
• Claris Lifesciences Limited
• Eisai Co. Ltd.
• F. Hoffmann-La Roche Ltd.
• Fresenius SE & Co. KGaA
• Hikma Pharmaceuticals PLC
• Mylan N.V.
• Novartis AG
• Pacira Pharmaceuticals, Inc.
• Pfizer Inc.
• Piramal Enterprises LTD
• Septodont Healthcare India Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Limited
• Viatris Inc.

LIST OF FIGURES

• FIGURE 1. ANESTHETIC DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. ANESTHETIC DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANESTHETIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. ANESTHETIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. ANESTHETIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANESTHETIC DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANESTHETIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANESTHETIC DRUGS MARKET DYNAMICS
• TABLE 7. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL ANESTHESIA DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHESIA DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGIONAL ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INHALATIONAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY TOPICAL:, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. CANADA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. CANADA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. CANADA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. CHINA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 72. CHINA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. CHINA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 74. CHINA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. INDIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 77. INDIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. INDIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 79. INDIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 161. ITALY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 163. ITALY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. ITALY ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 165. ITALY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. POLAND ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 183. POLAND ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. POLAND ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 185. POLAND ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. QATAR ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 188. QATAR ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. QATAR ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 190. QATAR ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 236. ANESTHETIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 237. ANESTHETIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

The Anesthetic Drugs Market was valued at USD 5.03 billion in 2023, expected to reach USD 5.35 billion in 2024, and is projected to grow at a CAGR of 6.54%, to USD 7.83 billion by 2030.

The anesthetic drugs market encompasses a variety of pharmaceutical products used in surgical procedures and pain management. These drugs, which include general anesthetics, local anesthetics, and regional anesthetics, are critical for inducing loss of sensation in patients, allowing medical professionals to perform intricate surgeries safely and with minimized distress. The necessity of anesthetic drugs is underscored by their applications in surgeries ranging from minor outpatient procedures to complex and invasive operations. Moreover, with an aging global population and increasing surgical interventions, the demand for effective anesthetic agents is set to rise. Hospitals, ambulatory surgical centers, and clinics represent the primary end-use segments within this market. Several key factors are driving growth in this sector; advances in drug formulations promise shorter recovery times and reduced side effects, while increasing global healthcare expenditures enhance market expansion. Additionally, the emergence of minimally invasive surgical procedures and the growing trend of outpatient surgeries expand the application of anesthetic drugs. However, the market faces limitations, such as strict regulatory requirements and potential side effects associated with anesthetic use, which can restrain development. Furthermore, in regions with limited healthcare infrastructure, access to these drugs remains challenging. Innovation and research areas with strong potential include the development of more personalized anesthetic solutions based on genetic profiling, and enhanced drug delivery systems, such as nanotechnology, to improve drug efficacy and safety. New partnerships and collaborations between pharmaceutical companies and research institutes can accelerate innovation, making it critical for businesses to stay abreast of technological advancements and regulatory changes. The anesthetic drugs market is poised for significant growth but requires strategic navigation of its complex landscape to harness its full potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anesthetic Drugs Market

The Anesthetic Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing number of surgeries being performed worldwide
  • Significant growth in demand for post-operative pain relief options
  • Rise in aging population and prevalence of cardiovascular and respiratory system-related diseases
• Market Restraints
  • Side effects associated with drug such as ketamine
• Market Opportunities
  • Advancements in drug delivery technologies
  • Increasing healthcare expenditure and development of new drugs
• Market Challenges
  • Dearth of skilled-anesthetics

Porter's Five Forces: A Strategic Tool for Navigating the Anesthetic Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anesthetic Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anesthetic Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anesthetic Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anesthetic Drugs Market

A detailed market share analysis in the Anesthetic Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anesthetic Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anesthetic Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anesthetic Drugs Market

A strategic analysis of the Anesthetic Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anesthetic Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Apotex Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, B. Braun Melsungen AG by B. Braun SE, Baxter International Inc., Boehringer Ingelheim International GmbH, Claris Lifesciences Limited, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals PLC, Mylan N.V., Novartis AG, Pacira Pharmaceuticals, Inc., Pfizer Inc., Piramal Enterprises LTD, Septodont Healthcare India Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Anesthetic Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Type, market is studied across General Anesthesia Drugs, Local Anesthesia Drugs, and Regional Anesthesia.
• Based on Route of Administration, market is studied across Inhalation and Injection.
• Based on Application, market is studied across Cosmetic Surgery, Dental Surgery, General Surgery, and Plastic Surgery.
• Based on Mode of Administration, market is studied across Inhalational, Intravenous, and Topical:.
• Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing number of surgeries being performed worldwide
    • 5.1.1.2. Significant growth in demand for post-operative pain relief options
    • 5.1.1.3. Rise in aging population and prevalence of cardiovascular and respiratory system-related diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Side effects associated with drug such as ketamine
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in drug delivery technologies
    • 5.1.3.2. Increasing healthcare expenditure and development of new drugs
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled-anesthetics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Drug Type: Crucial need for general anesthesia drugs for extensive and invasive surgeries
  • 5.2.2. Application: Utilization of anesthetic drugs for general surgeries to facilitate effective pain management
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Anesthetic Drugs Market, by Drug Type

• 6.1. Introduction
• 6.2. General Anesthesia Drugs
• 6.3. Local Anesthesia Drugs
• 6.4. Regional Anesthesia

7. Anesthetic Drugs Market, by Route of Administration

• 7.1. Introduction
• 7.2. Inhalation
• 7.3. Injection

8. Anesthetic Drugs Market, by Application

• 8.1. Introduction
• 8.2. Cosmetic Surgery
• 8.3. Dental Surgery
• 8.4. General Surgery
• 8.5. Plastic Surgery

9. Anesthetic Drugs Market, by Mode of Administration

• 9.1. Introduction
• 9.2. Inhalational
• 9.3. Intravenous

9.4. Topical:

10. Anesthetic Drugs Market, by End User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Clinics
• 10.4. Hospitals

11. Americas Anesthetic Drugs Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Anesthetic Drugs Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Anesthetic Drugs Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Baxter International Inc. Expands U.S. Portfolio with Innovative Injectable Products
  • 14.3.2. Hikma Pharmaceuticals Broadens US Market Offering with Launch of Fentanyl Citrate Injection
  • 14.3.3. Advancing Postoperative Pain Management: FDA's New Guidance on Developing Long-Lasting Local Anesthetics
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Apotex Inc.
• 3. Aspen Pharmacare Holdings Limited
• 4. AstraZeneca PLC
• 5. B. Braun Melsungen AG by B. Braun SE
• 6. Baxter International Inc.
• 7. Boehringer Ingelheim International GmbH
• 8. Claris Lifesciences Limited
• 9. Eisai Co. Ltd.
• 10. F. Hoffmann-La Roche Ltd.
• 11. Fresenius SE & Co. KGaA
• 12. Hikma Pharmaceuticals PLC
• 13. Mylan N.V.
• 14. Novartis AG
• 15. Pacira Pharmaceuticals, Inc.
• 16. Pfizer Inc.
• 17. Piramal Enterprises LTD
• 18. Septodont Healthcare India Pvt. Ltd.
• 19. Sun Pharmaceutical Industries Ltd.
• 20. Teva Pharmaceutical Industries Limited
• 21. Viatris Inc.